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        Introduction 
  Mutations of the   nucleophosmin   ( NPM  ) gene occur in    35% 
of acute myelogenous leukemias (AMLs) and are mutually ex-
clusive with the major AML-associated genetic abnormalities, 
which suggests that they represent an initiating event in myeloid 
leukemogenesis (  Falini et al., 2005  ). The underlying mecha-
nisms, however, remain unknown. 
  NPM is a ubiquitously expressed nucleolar protein that 
functions as a molecular chaperone (  Okuwaki et al., 2001  ) and 
shuttles between the nucleus and cytoplasm (  Borer et al., 1989  ). 
It is part of a high  –  molecular weight complex and physically 
interacts with many cellular proteins including p53 (  Colombo 
et al., 2002  ), Mdm2 (  Kurki et al., 2004  ), and Arf (  Itahana et al., 
2003  ). NPM binds Arf and protects it from degradation (  Kuo 
et al., 2004  ). In   NPM   /      cells, the Arf protein looses its nucleo-
lar localization and becomes markedly unstable, which suggests 
that NPM is required for correct localization and stability of Arf 
(  Colombo et al., 2005  ). This function of NPM is lost in mutant 
NPM (NPMmut), which contains a de novo nuclear export sig-
nal and mainly localizes in the cytoplasm ( Mariano et al., 2006 ). 
NPMmut competes with wild-type (WT) NPM for Arf binding 
and targets Arf to the cytoplasm, where it becomes more sus-
ceptible to degradation (  Colombo et al., 2006  ). 
 Preliminary evidence suggests, however, that NPM controls 
other intracellular pathways that negatively regulate cell prolifer-
ation. In   NPM   /      embryos, cells proliferate more actively, ac-
cumulate DNA damage, and undergo p53-dependent apoptosis 
(  Colombo et al., 2005  ), a picture that is reminiscent of the DNA 
damage response induced by oncogene expression in primary 
cells (  Bartkova et al., 2005  ).   NPM   /      cells also show aberrant 
mitotic fi  gures with multiple centrosomes (  Grisendi et al., 2005  ) 
and are more susceptible to transformation by activated onco-
genes such as Myc and Ras (  Colombo et al., 2005  ). Consistently, 
  NPM ±    mice show accelerated Myc-induced lymphomagenesis 
(  Grisendi et al., 2005  ). We report here that NPM and its AML-
associated mutant regulate the stability of the c-Myc protein. 
  Results and discussion 
  We initially analyzed levels of c-Myc in lysates from   NPM   /     
and WT whole embryos. Western blotting (WB) revealed a 
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utations leading to aberrant cytoplasmic local-
ization of nucleophosmin (NPM) are the most 
frequent genetic alteration in acute myeloge-
nous leukemia (AML). NPM binds the Arf tumor suppres-
sor and protects it from degradation. The AML-associated 
NPM mutant (NPMmut) also binds p19Arf but is unable to 
protect it from degradation, which suggests that inactiva-
tion of p19Arf contributes to leukemogenesis in AMLs. 
We report here that NPM regulates turnover of the c-Myc 
oncoprotein by acting on the F-box protein Fbw7    , a 
component of the E3 ligase complex involved in the 
ubiquitination and proteasome degradation of c-Myc. 
NPM was required for nucleolar localization and stabili-
zation of Fbw7    . As a consequence, c-Myc was stabilized 
in cells lacking NPM. Expression of NPMmut also led to 
c-Myc stabilization because of its ability to interact with 
Fbw7     and delocalize it to the cytoplasm, where it is 
degraded. Because Fbw7 induces degradation of other 
growth-promoting proteins, the NPM  –  Fbw7 interaction 
emerges as a central tumor suppressor mechanism in hu-
man cancer.
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de novo protein synthesis widely used to measure c-Myc protein 
half-life;   Popov et al., 2007  ) and lysed at different time points to 
follow c-Myc protein degradation. As an internal control, we 
monitored expression of    -tubulin  ( Colombo  et  al.,  2005 ). 
WB in the   p53   /      MEFs  confi  rmed that c-Myc is an unstable 
protein with a half-life of     20 min (  Gregory and Hann, 2000  ). 
In the dKO cells, instead, the c-Myc protein appeared to be more 
stable, with a calculated half-life of     40 min (  Fig. 1 f  ). It ap-
pears, therefore, that NPM regulates stability of the c-Myc pro-
tein. To confi  rm the NPM dependency, we reconstituted NPM 
expression in dKO cells and measured levels of c-Myc protein, 
c-Myc protein stability, and c-Myc target gene expression. 
Notably, NPM reexpression in   NPM   /      MEFs reduced the 
half-life of the c-Myc protein (  Fig. 1 g  , left; and   Fig. 1 h  ), its 
steady-state and serum-stimulated levels (  Fig. 1 g  , middle), and 
expression of c-Myc target genes after serum stimulation (  Fig. 1 g  , 
right). Finally, to investigate the effects of p53 on c-Myc ex-
pression, we evaluated levels of   c-myc   mRNA/protein  and  c-Myc 
protein stability in WT and   p53  -null MEFs. As shown in Fig. S1 a 
(available at http://www.jcb.org/cgi/content/full/jcb.200711040/
DC1), a lack of p53 led to increased levels of   c-Myc   mRNA and 
protein, as previously described (  Ho et al., 2005  ). Notably, 
marked increase of the c-Myc protein in the   NPM   /      samples 
( Fig.  1  a ,  left). 
[ID]FIG1[/ID]  Levels of   c - myc   mRNA, instead, were equivalent 
in the two samples (  Fig. 1 a  , right), which suggests that the in-
creased levels of c-Myc protein in the   NPM   /      embryos were 
caused by enhanced protein stability. Accordingly, we observed 
a moderate increase in mRNA expression for several c-Myc tar-
get genes in   NPM   /      embryos (  Fig. 1 b  ). 
  We then examined c-Myc levels in cultured fi  broblasts 
(mouse embryonic fi  broblasts [MEFs]) from double knockout 
  NPM   /  ;p53  /      embryos (dKO) and, as controls, MEFs 
from   p53   /      embryos.   NPM   /      MEFs, in fact, do not grow 
in culture due to the accumulation of DNA damage and rapid 
acquisition of a p53-dependent senescence-like phenotype 
(  Colombo et al., 2005  ). c-Myc protein was elevated in dKO 
MEFs as compared with the   p53   /      cells (  Fig. 1 c  , left) in the 
absence of signifi  cant variations of the amount of   c - myc   tran-
scripts (  Fig. 1 c  , right). dKO MEFs also showed increased binding 
of c-Myc to target promoters, as assayed by chromatin immuno-
precipitation (ChIP;   Fig. 1 d  ), and an increased induction of c-Myc 
target genes after serum stimulation of starved cells (  Fig. 1 e  ). 
To measure the half-life of the c-Myc protein, dKO and control 
cells were treated with cycloheximide (CHX; an inhibitor of 
  Figure 1.       NPM regulates c-Myc protein stability.   (a, left) WB analysis of two NPM WT (Nos. 1 and 2) and knockout (KO; Nos. 2 and 3) embryos at 10.5 d 
post coitum (  Colombo et al., 2005  ). (right)   c-Myc   mRNA levels in the same embryos evaluated by QPCR (results are normalized against WT samples). 
(b) Expression of c-Myc target genes analyzed by QPCR using mRNA from WT and NPM KO embryos. Expression was standardized with ubiquitin and 
normalized against the control WT RNAs. (c) c-Myc protein levels (left) and   c-Myc   mRNA levels (right) in   p53    /       and dKO MEFs. (d) QPCR of anti c-Myc 
ChIP. The percentage of DNA bound to c-Myc was calculated as described previously (  Frank et al., 2001  ). (e) QPCR analysis of c-Myc target genes at 8 h 
after serum treatment. Results analyzed as in panel b. (f) c-Myc protein level in   p53    /       and dKO MEFs. Cells were treated with CHX and harvested 
at the indicated time points. (g, left) c-Myc protein levels in   p53    /       and dKO MEFs infected with retroviruses expressing the GFP-NPM1 protein (+NPM) 
or control retroviruses. (middle) WB analysis of the same cells during serum starvation and upon serum release. (right) QPCR analysis of c-Myc target gene 
expression after serum treatment (8 h) as in panel d. (h) c-Myc protein level in   p53    /      , dKO, and dKO + GFP-NPM MEFs as described in panel f. 
Data represent the mean of three determinations   ±   SEM.     21 NUCLEOPHOSMIN REGULATES   C  -MYC TURNOVER   • Bonetti et al. 
its stabilization (  Fig. 2 a  ), and binding to target promoters 
( Fig.  2  b ). 
[ID]FIG2[/ID]  Overexpression of Fbw7     reduced Myc-ER protein 
stabilization and promoter occupancy in   p53   /      cells (  Fig. 2, 
a and b  ) but had no effects in dKO cells (  Fig. 2, a and b  ). The same 
experiments were repeated in the dKO and   p53   /      parental 
cells. Overexpression of Fbw7     slightly yet consistently reduced 
levels of endogenous c-Myc protein and c-Myc occupancy at 
target promoters in the p53   /    cells but not in dKO cells 
( Fig.  2,  c  and d  ). It appears, therefore, that NPM expression is 
critical for the ability of Fbw7     to regulate c-Myc protein levels. 
  We than analyzed whether NPM interacts physically with 
Fbw7     and affects the localization and expression levels of 
Fbw7    . Coimmuprecipitation experiments revealed that NPM 
forms a complex in vivo with ectopically expressed tagged 
Fbw7     (  Fig. 2 e  , left). The interaction is likely to be direct, as 
recombinant GST-NPM bound in vitro translated Fbw7     ( Fig.  2  f ). 
No interactions were detected between NPM and Fbw7     ( Fig.  2, 
e and f  ) or      ( Fig.  2  e ). 
 Immunofl  uorescence (IF) analysis (  Fig. 3 a  , top) showed 
that Fbw7     was concentrated in the nucleoli of   p53   /      cells, 
as expected. 
[ID]FIG3[/ID]  In dKO MEFs, the nucleolar localization of Fbw7   
was lost, replaced by a diffuse nuclear staining. These altera-
tions in localization were specifi  c for the Fbw7     isoform 
however, the stability of the c-Myc protein was the same in the 
two cell types (Fig. S1 b). Down-regulation of NPM expression 
by siRNA induced up-regulation of c-Myc protein levels, but 
not of the corresponding mRNA, in both the WT and   p53   /     
MEFs (Fig. S2 c), thus indicating that the effect of NPM silenc-
ing on c-Myc protein is p53 independent. 
  c-Myc is degraded through the ubiquitin  –  proteasome 
pathway (  Salghetti et al., 1999  ), and its ubiquitination is con-
trolled by two different F-box proteins, Fbw7 and Skp2 (  Hann, 
2006  ). Three isoforms of Fbw7 have been described that dif-
fer in their intracellular localization: Fbw7     (nuclear diffuse), 
Fbw7     (cytoplasmic), and Fbw7     (nucleolar).  Although  all 
three Fbw7 isoforms have the potential to bind it, preliminary 
evidence suggests that c-Myc is prevalently degraded by Fbw7    
(  Popov et al., 2007  ). Because NPM localizes to the nucleolus 
(where it colocalizes with Fbw7    ; Fig. S1 d), we investigated 
whether the Fbw7     isoform is involved in the regulation of 
c-Myc stability by NPM. The HA-tagged version of Fbw7     was 
overexpressed in dKO or p53   /    control cells previously engi-
neered with a Myc  –  estrogen receptor fusion protein (Myc-ER) 
whose activity is induced by treatment with 4-hydroxytamoxi-
fen (4-OHT). Treatment of   p53   /      control cells with OHT 
rapidly induced nuclear translocation of Myc-ER (not depicted), 
  Figure 2.       NPM is required for Fbw7     activity.   (a) WB analysis in   p53    /       and dKO MEFs infected with Myc-ER and, where indicated (+), HA-Fbw7      –
  expressing retroviruses. Cells were treated with 4-OHT for the indicated hours or left untreated (0 h). (b) QPCR of anti  –  c-Myc ChIP on target promoters (as in-
dicated) after 4-OHT treatment of the same cells as in panel a. (c) WB analysis in   p53    /       and dKO MEFs infected with retroviruses expressing HA-Fbw7     (+) 
or control retroviruses (    ) as indicated. c-Myc levels have been calculated by densimetric analysis, normalizing band intensity to actin and control   p53    /       
cells. (d) QPCR analysis of anti c-Myc ChIP on target promoters (as indicated) of the same cells as in panel c. (e) dKO MEFs were cotransfected with 
plasmids expressing NPM1 and ﬂ  ag-Fbw7     (left), ﬂ  ag-Fbw7     (middle), and ﬂ  ag-Fbw7     (right). Total lysates and immunoprecipitates were blotted with 
antibodies against NPM (NPMa) or anti-ﬂ  ag. (f) GST pull-down assay using in vitro translated  
35  S-labeled Fbw7     or Fbw7     and equal amounts of GST or 
GST-NPM proteins. Data represent the mean of three determinations   ±   SEM.     JCB • VOLUME 182 • NUMBER 1 • 2008  22
Fbw7    , instead, had no effect on OHT-treated dKO;Myc-ER 
cells (  Fig. 3 e  ). In summary, NPM positively regulates the nu-
cleolar localization and stability of the Fbw7     protein and is 
essential for the ability of Fbw7 to promote c-Myc degradation 
and limit cell transformation. The effect of NPM on c-Myc 
protein stability appears to be specifically exerted through 
Fbw7    , as we found no effects of NPM on expression and lo-
calization of Skp2 (Fig. S1 f). 
  c-Myc is frequently overexpressed in human cancers 
(  Adhikary and Eilers, 2005  ). c-Myc protein and/or RNA are also 
frequently overexpressed in AMLs, though the underlying 
molecular mechanisms are unknown (  Hoffman et al., 2002  ). 
We thus investigated whether expression of the AML-associated 
mutant of NPM leads to increased c-Myc expression. Ectopic 
expression of NPMmut in WT MEFs increased the steady-state 
because Fbw7     and  Fbw7    showed unchanged localization 
patterns in dKO and control cells (  Fig. 3 a  , bottom left and bot-
tom right). Fbw7     levels in the dKO MEFs were also consis-
tently lower than in the control   p53   /      MEFs (  Fig. 3 b  , left), 
whereas mRNAs were comparable (  Fig. 3 b  , right). CHX treat-
ment revealed that the half-life of Fbw7     in   p53   /      MEFs 
was     80 min but was reduced in the dKO to     30 min (  Fig. 3 c  ). 
The half-life of Fbw7     protein was not infl  uenced by ex-
pression of p53 (Fig. S1 e). Accordingly, Fbw7     dependent 
ubiquitination of c-Myc was reduced in NPM-null cells (  Fig. 3 d  ). 
Finally, we analyzed the ability of Fbw7     to inhibit c-Myc  –
  dependent transformation. Overexpression of Fbw7     induced 
a signifi  cant attenuation of the transformed phenotype in OHT-
treated   p53   /     ;Myc-ER cells, as shown by their reduced ability 
to form colonies in semisolid medium ( Fig. 3 e ). Overexpressed 
  Figure 3.       NPM is required Fbw7     nucleolar localization and stability.   (a) IF analysis of Fbw7     (top), Fbw7     (bottom left), and Fbw7     (bottom right) 
localization in p53    /     and dKO MEFs transiently transfected with the corresponding ﬂ  ag-Fbw7 constructs (green staining). Anti-ﬁ  brillarin staining (red) 
is shown as a marker for nucleoli. Bars, 10   μ  m. (b, left) WB analysis in   p53    /       and dKO MEFs infected with retroviruses expressing HA-Fbw7     (+) or 
control retroviruses (    ) as indicated. (right)   Fbw7       mRNA levels in   p53    /       and dKO MEFs. (c) HA-Fbw7     protein stability in   p53    /       and dKO MEFs. 
Cells were treated with CHX and harvested at the indicated time points. (d) Effects of Fbw7     expression on Myc ubiquitination in   p53    /       and dKO cells. 
  p53    /       (lanes 1  –  3) and dKO (lanes 4  –  6) MEFs were transfected with expression vectors for HA-tagged ubiquitin and ﬂ  ag-tagged Fbw7    , as indicated. 
Cell lysates were IPed with an anti-Myc antibody and blotted with anti-HA (to identify ubiquitinated myc; UB-myc) and anti-Myc (as control) antibodies. 
Levels of ﬂ  ag-Fbw7     in the input were analyzed with an anti-ﬂ  ag antibody. (e) Methylcellulose colony assay of   p53    /       and dKO MEFs expressing Myc-ER 
protein and infected with control (EV) or HA-Fbw7      –  expressing retroviruses. 4-OHT was added every 3 d; colonies were counted after 15 d. Data represent 
the mean of three determinations   ±   SEM. *, P   <   0.045.     23 NUCLEOPHOSMIN REGULATES   C  -MYC TURNOVER   • Bonetti et al. 
Moreover, in the presence of NPMmut, levels of Fbw7     pro-
tein were almost undetectable without changes of its mRNA 
(  Fig. 5 a  ). Treatment of the same cells with the MG132 protea-
some inhibitor for 2 h was suffi  cient to reconstitute Fbw7    
expression at levels similar to those observed in control cells 
without NPMmut (  Fig. 5 b  ). It appears, therefore, that NPMmut 
induces destabilization of Fbw7     and, as a consequence, sta-
bilization of c-Myc. 
  Finally, we investigated the mechanism through which 
NPMmut affects Fbw7     protein stability. Coimmunoprecipita-
tion experiments in   NPM -defi  cient MEFs revealed that NPMmut 
is able to form a complex with Fbw7     both in the absence 
( Fig.  5  c )  or  presence (not depicted) of WT NPM. IF analysis of 
the intracellular localization of Fbw7     in   p53   /      and dKO 
showed that expression of NPMmut causes, in both cell types, a 
partial displacement of Fbw7     from the nucleus to the cyto-
plasm (  Fig. 5 d   and Fig. S2 a, available at http://www.jcb.org/
cgi/content/full/jcb.200711040/DC1). These results were con-
fi  rmed by WB analysis of the levels of Fbw7     in nuclear and 
cytoplasmic fractions of   p53   /      and dKO cells in the presence 
or absence of NPMmut expression (  Fig. 5 e   and Fig. S2 b). 
The ability of NPMmut to delocalize Fbw7     and to form a com-
plex in cells also in the presence of the WT NPM suggest 
that NPMmut competes with the WT protein to bind Fbw7   . 
Consistently, we observed that up-regulation of c-Myc protein 
levels of the c-Myc protein in the absence of signifi  cant varia-
tions of the amount of   c-Myc   transcripts (  Fig. 4 a  ) and the ex-
pression of several Myc-target genes (  Fig. 4 b  ). 
[ID]FIG4[/ID]  These effects 
were maintained in   Arf   /      MEFs (  Fig. 4 e  ) and were thus in-
dependent on the presence of Arf in the nucleolus or its inter-
action with Myc (  Qi et al., 2004  ). 
  To gain evidence that this effect of NPMmut on c-Myc is 
biologically relevant, we analyzed growth of fi  broblasts ectopi-
cally expressing NPMmut. Overexpression of c-Myc induces 
DNA damage (  Dominguez-Sola et al., 2007  ) and, in primary 
fi  broblasts, a p53-dependent cellular checkpoint mainly charac-
terized by a reduction of cell proliferation; when cells are grown 
in low serum, it also induces apoptosis (  Zindy et al., 1998  ). 
Ectopic expression of the NPMmut in MEFs induced no modi-
fi  cations of Arf protein levels (Fig. S1 g), it increased the levels 
of     H2AX (a marker of DNA damage) and phosphorylated p53 
(Fig. S1 g), decreased the proliferation rate, and, in low serum 
conditions, induced massive apoptosis (  Fig. 4 c  ). Together, 
these results suggest that apoptosis induced by NPMmut ex-
pression follows c-Myc stabilization, induction of DNA dam-
age, and activation of p53. 
  We then investigated whether the effect of NPMmut on 
c-Myc stability is mediated by Fbw7    . The ability of over-
expressed Fbw7     to down-regulate Myc-ER levels was com-
pletely lost in the presence of NPMmut expression (  Fig. 5 a  ). 
[ID]FIG5[/ID]  
  Figure 4.       Mutant NPM stabilizes the c-Myc protein.   (a, left) WB analysis in WT and   NPM  ±     MEFs infected with retroviruses expressing NPMmut (Mut) or 
control (EV) retroviruses. (right)   c-Myc   mRNA levels in the same cell. (b) QPCR analysis of the indicated c-Myc target genes. (c, left) Growth curves of   NPM  ±     
MEFs infected with retroviruses expressing NPMmut or control (EV) retroviruses. 10 
4   cells were plated in presence of 10% serum (high serum) or 0.5% se-
rum (low serum) as indicated. (right) The percentage of apoptosis in the same cells maintained in low serum culture conditions for 24 h. (d) QPCR analysis 
of the indicated c-Myc target genes in   NPM  ±     MEFs infected with EV or NPMmut retroviruses. (e, left) WB analysis in   ARF    /      ,   p53    /      , and dKO MEFs 
infected with retroviruses expressing NPMmut (mut) or control (EV) retroviruses. (right)   c-Myc   mRNA levels in the same samples. (f) QPCR analysis of the 
indicated c-Myc target genes in the same cells as in panel e. Data represent the mean of three determinations   ±   SEM.     JCB • VOLUME 182 • NUMBER 1 • 2008  24
  In conclusion, our fi  ndings demonstrate that NPM regu-
lates c-Myc protein stability through its effect on the    -isoform 
of the F-box E3 ubiquitin ligase Fbw7. They are consistent with 
a model whereby NPM binds directly to Fbw7     and serves as a 
molecular chaperone to ensure its proper folding, nucleolar lo-
calization, and to prevent its degradation. This effect of NPM on 
Fbw7     is relevant for the regulation of one of its substrates, 
c-Myc, which, in fact, accumulates in the absence of NPM. 
  The effect of NPM on Fbw7 regulation, however, might 
be more complex. Other intracellular proteins are also Fbw7-
substrates, including Notch, cyclin E, and c-Jun (  Nakayama and 
Nakayama, 2005  ). Because NPM does not regulate the Fbw7    
and Fbw7     isoforms, it might allow regulation of Fbw7   -
specifi  c substrates or the nucleolar site of degradation of Fbw7-
common substrates. Close inspection of the regulation of Notch, 
cyclin E, and c-Jun protein stability and function in   NPM   /     
cells might help to elucidate this question. 
  The leukemia-associated mutant of NPM interacts with 
Fbw7     and delocalizes it to the cytoplasm, thus favoring its 
degradation. As a consequence, c-Myc protein levels are in-
creased in cells expressing the NPMmut. Notably, c-Myc pro-
tein is frequently overexpressed in AMLs and stabilized in 
several leukemia cell lines (  Hoffman et al., 2002  ), and c-Myc 
overexpression favors myeloid leukemogenesis in mouse mod-
els (  Luo et al., 2005  ). Thus, the pathway of c-Myc degradation 
is relevant for human cancer, which suggests that elevated 
levels (  Fig. 4 a  ) and Myc-target gene expression (  Fig. 4 d  ) by 
NPMmut were facilitated in NPM+/     MEFs, which carry re-
duced levels of NPM (  Grisendi et al., 2005  ). 
  To investigate if the cytoplasmic displacement of Fbw7    
correlates with its degradation, we analyzed levels of the Fbw7    
protein upon treatment of   p53   /      and dKO cells with the 
nuclear-export inhibitor leptomycin B (LMB) as compared with 
treatment with the proteasome inhibitor MG132. As shown in 
  Fig. 5 f   and Fig. S2 c, LMB and MG132 increased the levels of 
Fbw7     to the same extent in both cell types. However, despite 
the fact that NPMmut induced degradation of Fbw7     in dKO 
cells (  Fig. 4 e  ), it did not increase c-Myc protein levels in the 
same cells, which is consistent with the observation that, in the 
absence of WT NPM, the function of Fbw7     is lost, regardless 
of its nuclear or cytoplasmic localization (  Fig. 2, a  –  c  ). These 
data are consistent with the reported chaperone activity of 
WT NPM in maintaining the proper folding and activity of its 
interactors (  Szebeni and Olson, 1999  ). In summary, we observed 
that expression of NPMmut induces delocalization and acceler-
ated degradation of Fbw7     also in the absence of the WT NPM 
protein, thus demonstrating that the effect of the mutant NPM 
on Fbw7     is direct. Furthermore, because LMB treatment induced 
nuclear relocalization of NPMmut and Fbw7     and restoration 
of physiological levels of Fbw7     protein, aberrant cytoplasmic 
localization of the NPMmut appears critical for the degradation 
of Fbw7   . 
  Figure 5.       Mutant NPM delocalizes and destabilizes Fbw7      . (a, left) WB analysis in   p53    /      ;Myc-ER cells infected with empty (No. 2) or HA-Fbw7    -
expressing (No. 4) retroviruses. HA-Fbw7      –  infected cells were reinfected with empty or NPMmut-expressing lentiviruses (also expressing GFP as marker). 
Cells were treated for 2 h with 4-OHT (Nos. 2  –  4). (right) QPCR analysis of   Fbw7       mRNA levels in samples Nos. 3 and 4. Data represent the mean of three 
determinations   ±   SEM. (b) WB analysis in the same cells as in panel a. Cells were or were not treated with MG132 for 2 h, as indicated. (c) dKO MEFs 
were cotransfected with plasmids expressing ﬂ  ag-Fbw7     and NPMmut or the empty vector, as indicated. Total lysates and IPs were blotted with antibodies 
against NPMmut or the ﬂ  ag epitope. (d) IF analysis of   p53    /       MEFs infected with GFP-NPMmut  –   and ﬂ  ag-Fbw7     (red staining)-expressing constructs. 
A merge of the NPMmut, Fbw7    , and DAPI staining is also shown. Bar, 10   μ  m. (e) Nucleus  –  cytoplasm fractionation in   p53    /       MEFs expressing ﬂ  ag-
Fbw7     infected with GFP-NPMmut or control (EV) retroviruses. Total cell lysates (T) or cellular fractions (C, cytoplasm; N, nucleus) were analyzed by WB as 
indicated. (f) The same cells as in panel e were or were not treated with 1   μ  M LMB or MG132 for 3 h, as indicated. Expression of Fbw7     was analyzed 
by WB on total cells lysates using anti-ﬂ  ag antibodies.     25 NUCLEOPHOSMIN REGULATES   C  -MYC TURNOVER   • Bonetti et al. 
  Apoptosis assay 
  Cells were harvested and double ﬁ  xed in 1% formaldehyde and then cold 
ethanol. After permeabilization in 0.1% Triton X-100 for 10 min, cells were 
stained with anti-cleaved caspase3 antibody (Cell Signaling Technology), 
washed, and incubated with cy5-conjugated secondary antibody. The per-
centage of positive cells was evaluated by FACS analysis. 
  Nuclear and cytoplasmic fractionation 
  MEFs were washed twice in ice-cold hypotonic buffer (20 mM Hepes, pH 7, 
5 mM potassium-acetate, 0.5 mM MgCl2, and 0.5 mM DTT) supple-
mented with protease inhibitors, and then swollen on ice for 10 min. After 
buffer removal, cells were collected by scraping and disrupted by vigorous 
pipetting. The integrity of nuclei was checked with the microscope after try-
pan blue staining. Nuclei were pelleted at 4,000 rpm for 5 min, and super-
natants were stored as cytoplasmic fraction. The nuclear fraction was 
washed twice with hypotonic buffer and then lysed in Laemmli buffer. Equal 
volumes of nuclear and cytosolic fractions were loaded on an SDS-poly-
acrylamide gel for WB analysis. 
  Statistical analysis 
  Statistical signiﬁ  cance was evaluated by nonparametric Mann-Whitney 
  U   test (Wilcoxon-Kruskal Wallis) to analyze variables that were not normally 
distributed. Signiﬁ  cance was deﬁ  ned at P   <   0.05 (two-tailed test). 
  Online supplemental material 
  Fig. S1 shows control experiments regarding the role of p53 in regulating 
c-Myc and Fbw7     half-lives, the role of NPM in controlling Skp2 protein lo-
calization and stability, and the expression levels of different proteins upon 
NPMmut expression in MEFs. Fig. S2 shows the effect of NPMmut expression 
in dKO MEFs on Fbw7     localization and stability. Table S1 shows all the 
primers used in the QPCR experiments. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200711040/DC1. 
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